Anesthesia management in Charcot-Marie-Tooth disease (CMT) requires careful consideration due to the potential for adverse reactions to certain anesthetic agents and the increased risk of perioperative complications. Patients with CMT may exhibit variable and unpredictable responses to non-depolarizing neuromuscular blocking drugs and volatile anesthetics, necessitating individualized care and close monitoring.
Anesthesiologists must be aware of the potential for malignant hyperthermia and cardiorespiratory complications in this patient population. To further your knowledge on anesthesia management in CMT, you can download the PowerPoint file here, which provides detailed information and recommendations.
